The action of alcohols and other non-ionic surface active substances on the sodium current of the squid giant axon.
The effects of several n-alkanols and n-alkyl oxyethylene alcohols, methyl octanoate, glycerol 1-monooctanoate and dioctanoyl phosphatidylcholine on the ionic currents and electrical capacity of the squid giant axon membrane have been examined. The peak inward current in voltage-clamped axons was reduced reversibly by each substance. For n-pentanol to n-decanol the concentrations required to suppress the peak inward current by 50% were determined. From these data, it was estimated that the standard free energy per CH2 for adsorption to the site of action was -3.04 kJ mole-1, as compared with -3.11 kJ mole-1 for adsorption into phospholipid bilayers or an n-alkane/aqueous solution interface. The membrane capacity at 100 kHz was not greatly by any of the test substances at concentrations which reduced the inward current by 50%. Na currents under voltage clamp were recorded in intracellularly perfused axons before, during and sometimes after exposure to the test substances and the records were fitted with equations similar to those proposed by Hodgkin & Huxley (1952). Shifts in the curves of the steady-state activation and inactivation parameters (m infinity and h infinity) against membrane potential, changes in the peak heights of the activation and inactivation time constants (tau m and tau h) and reductions in the maximum Na conductance (gNa) have been tabulated. All of the test substances shifted the voltage dependence of the steady-state activation in the depolarizing direction and lowered the peak time constants for both activation and inactivation. The origins of these effects, and of the differences in the present results from those of the hydrocarbons (Haydon & Urban, 1983), have been discussed in terms of the physico-chemical properties of the two groups of substances and with reference to their effects on artificial membranes.
D000438:Alcohols / Q000494:pharmacology*; D000818:Animals; D001369:Axons / Q000502:physiology*; D002210:Caprylates / Q000494:pharmacology; D049832:Decapodiformes; D005989:Glycerides / Q000494:pharmacology; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D010713:Phosphatidylcholines / Q000494:pharmacology*; D012964:Sodium / Q000502:physiology*; D013501:Surface-Active Agents / Q000494:pharmacology*
D000438:Alcohols; D002210:Caprylates; D005989:Glycerides; D007473:Ion Channels; D010713:Phosphatidylcholines; D013501:Surface-Active Agents; C039152:1,2-octanoylphosphatidylcholine; C039151:methyl octanoate; D012964:Sodium; C025343:monooctanoin